← Open Payments lookup

NATALIE SLOAN: Open Payments

NPI 1710433131 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,751 in 72 payments from 12 companies in 2025. Trend: 2023 $1,449 · 2024 $2,001 · 2025 $1,751

Food & beverage: $1,751
CompanyPaymentsAmount
Madrigal Pharmaceuticals13$460
Janssen Biotech, Inc.12$374
ABBVIE INC.21$357
Salix Pharmaceuticals, a division of Bausch Health US, LLC9$175
Celltrion USA Inc.5$104
Daiichi Sankyo Inc.3$72
Takeda Pharmaceuticals U.S.A., Inc.2$66
Braintree Laboratories, Inc.2$48
Phathom Pharmaceuticals, Inc.2$29
Intercept Pharmaceuticals, Inc.1$25

Products named: REZDIFFRA, TREMFYA, RINVOQ, XIFAXAN, VEGZELMA, LINZESS, INJECTAFER, EOHILIA.

Industry payments across CA — which companies pay providers there.